日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sphingosine-1-Phosphate Receptor 3 Confers Tumor Metastasis in Lung Cancer Resistant to Third-Generation EGFR Inhibitor

鞘氨醇-1-磷酸受体3赋予对第三代EGFR抑制剂耐药的肺癌肿瘤转移能力

Lai, Mengzhen; Chen, Jiaying; Qin, Ye; Zhang, Hui; Pan, Zilu; Zhang, Tao; Tong, Linjiang; Tang, Haotian; Bai, Gang; Liu, Qiupei; Li, Yan; Feng, Fang; Song, Peiran; Liu, Yingqiang; Chen, Yi; Fang, Yan; Tang, Bencan; Geng, Meiyu; Yu, Ker; Chen, Hao; Ding, Jian; Xie, Hua

Novel anti-HER2 nanobody-drug conjugates with enhanced penetration of solid tumor and BBB, reduced systemic exposure and superior antitumor efficacy.

新型抗 HER2 纳米抗体-药物偶联物,具有增强的实体瘤和血脑屏障渗透性、降低的全身暴露和优异的抗肿瘤疗效。

Wang Yue, Liu Liang, Yang Qi-Yu, Yu Ker

Tissue factor promotes TREX1 protein stability to evade cGAS-STING innate immune response in pancreatic ductal adenocarcinoma

组织因子促进TREX1蛋白稳定性,从而逃避胰腺导管腺癌中的cGAS-STING先天免疫反应

Xue, Yinyin; Wang, Yue; Ren, Zhiqiang; Yu, Ker

CD63-Mediated SARS-CoV-2 RBD Fusion Neoantigen DNA Vaccine Enhances Antitumor Immune Response in a Mouse Panc02 Model via EV-Targeted Delivery.

CD63介导的SARS-CoV-2 RBD融合新抗原DNA疫苗通过EV靶向递送增强小鼠Panc02模型中的抗肿瘤免疫反应。

Liu Guang, Yuan Ziqing, Wu Ziyi, Yang Qiyv, Ding Tingbo, Yu Ker, Dong Jibin

COVID-19 Bivalent Booster in Pregnancy: Maternal and Neonatal Antibody Response to Omicron BA.5, BQ.1, BF.7 and XBB.1.5 SARS-CoV-2

妊娠期新冠病毒二价加强针:母体和新生儿对 Omicron BA.5、BQ.1、BF.7 和 XBB.1.5 SARS-CoV-2 的抗体反应

Chen, Wei-Chun; Hu, Shu-Yu; Shen, Ching-Fen; Chuang, Hui-Yu; Ker, Chin-Ru; Shen, Ching-Ju; Cheng, Chao-Min

Novel-smoothened inhibitors for therapeutic targeting of naïve and drug-resistant hedgehog pathway-driven cancers

新型平滑抑制剂用于治疗未经治疗和耐药的 Hedgehog 通路驱动型癌症

Li, Qing-Rou; Zhao, Hui; Zhang, Xue-Sai; Lang, Henk; Yu, Ker